Vitelle Irospan Interactions
There are 116 drugs known to interact with Vitelle Irospan (ascorbic acid/ferrous sulfate), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 4 are major, 84 are moderate, and 28 are minor.
Medications known to interact with Vitelle Irospan
Note: Showing generic names only.
- cabotegravir
- calcium carbonate
- cefdinir
- chloramphenicol
- cimetidine
- cinoxacin
- ciprofloxacin
- cisplatin
- deferiprone
- deferoxamine
- delafloxacin
- demeclocycline
- dexlansoprazole
- dextroamphetamine
- dicumarol
- dihydroxyaluminum sodium carbonate
- dimercaprol
- dolutegravir
- doxorubicin
- doxorubicin liposomal
- doxycycline
- eltrombopag
- elvitegravir
- enoxacin
- entacapone
- ephedrine
- ephedrine nasal
- esomeprazole
- estradiol
- ethinyl estradiol
- etidronate
- lansoprazole
- lanthanum carbonate
- levodopa
- levofloxacin
- levothyroxine
- levothyroxine / liothyronine
- liothyronine
- liotrix
- lisdexamfetamine
- lomefloxacin
- ma huang
- magaldrate
- magnesium carbonate
- magnesium hydroxide
- magnesium oxide
- methadone
- methamphetamine
- methyldopa
- mexiletine
- minocycline
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- paclitaxel
- paclitaxel protein-bound
- pancreatin
- pancrelipase
- pantoprazole
- patiromer
- penicillamine
- propranolol
- pseudoephedrine
- sarecycline
- saw palmetto
- sodium bicarbonate
- sodium citrate
- sodium ferric gluconate complex
- sodium polystyrene sulfonate
- sparfloxacin
- st. john's wort
- sucralfate
Vitelle Irospan alcohol/food interactions
There are 2 alcohol/food interactions with Vitelle Irospan (ascorbic acid/ferrous sulfate).
Vitelle Irospan disease interactions
There are 7 disease interactions with Vitelle Irospan (ascorbic acid/ferrous sulfate) which include:
- hemoglobin abnormalities
- hemolysis
- kidney stones
- sodium
- achlorhydria
- gastrointestinal irritation
- dialysis
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.